Cipher Pharmaceuticals Inc. (TSX:CPH)
Canada flag Canada · Delayed Price · Currency is CAD
13.95
-0.21 (-1.48%)
Aug 28, 2026, 4:00 PM EST

Cipher Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
28.9927.3311.5520.3826.647.76
Depreciation & Amortization
7.177.224.021.230.990.7
Other Amortization
0.180.160.06---
Loss (Gain) From Sale of Assets
-0.19-0.13---0.76
Stock-Based Compensation
1.691.741.071.190.40.14
Other Operating Activities
-9.91-11.82-6.1-3.53-14.27-0.22
Change in Accounts Receivable
-0.272.65-8.771.71-0.142.56
Change in Inventory
-3.67-2.43.6-0.83-0.5-0.76
Change in Accounts Payable
1.880.521.280.53-1.45-1.23
Change in Unearned Revenue
-5.0212.790.27-0.190.14
Change in Income Taxes
-0.01-0.050.05-4.97-0.853.59
Change in Other Net Operating Assets
1.2-0.520.010.010.10.37
Operating Cash Flow
27.0629.7319.551610.7313.81
Operating Cash Flow Growth
28.07%52.08%22.17%49.18%-22.36%18.17%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.04-0.03-80.04-0.14-0.08-
Sale of Property, Plant & Equipment
0.20.13----
Sale (Purchase) of Intangibles
-0.97-0.17----
Investing Cash Flow
-0.82-0.07-80.04-0.14-0.08-

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Long-Term Debt Issued
--40---
Long-Term Debt Repaid
--35.31-0.23-0.11-0.06-0.83
Net Debt Issued (Repaid)
-25.31-35.3139.77-0.11-0.06-0.83
Issuance of Common Stock
0.380.220.150.430.130.08
Repurchase of Common Stock
-3.24-5.38-0.18-5.56-1.99-1.72
Other Financing Activities
---0.45---
Financing Cash Flow
-28.16-40.4739.3-5.24-1.91-2.47

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.310.47-0.790.38-0.440.06
Net Cash Flow
-2.23-10.34-21.9910.998.2911.41

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
27.0229.7-60.515.8610.6413.81
Free Cash Flow Growth
---48.96%-22.95%18.27%
Free Cash Flow Margin
54.44%58.87%-181.33%74.92%51.48%62.95%
Free Cash Flow Per Share
1.051.14-2.400.620.410.52
Levered Free Cash Flow
19.2123.99-67.765.484.713.62
Unlevered Free Cash Flow
19.3124.56-67.825.484.713.67

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
-0.875.238.95-3.28-3.034.68